# An Interaction Study of Ketoconazole/Verapamil Versus AZD1305

> **NCT00707551** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 27 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ketoconazole
- **DRUG:** Verapamil
- **DRUG:** AZD1305

## Key facts

- **NCT ID:** NCT00707551
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707551, "An Interaction Study of Ketoconazole/Verapamil Versus AZD1305". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00707551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*